HALIFAX,
Dec. 9, 2013 /CNW/ - MedMira, Inc.
(MedMira) (TSXV: MIR), a developer of rapid diagnostic technology
and solutions, today announced the appointment of Jelle Kuypers as Chief Financial Officer.
"I'm excited to join the team at MedMira. In
addition to leading the Company's financial functions, I look
forward to working with the executive and Board to execute on the
Company's strategic plan and grow our global presence in order to
increase shareholder value," said Jelle
Kuypers, Chief Financial Officer, MedMira Inc..
Kuypers brings more than 15 years of leadership
experience in finance and treasury, strategic and operational
planning, as well as business development. He has in-depth
experience in creating and developing high-performance finance
teams working in global markets including Europe, North
America and the Middle
East.
"On behalf of the Board of Directors, I welcome
Jelle to the team and look forward to MedMira benefiting from the
wealth of financial expertise, corporate strategy building, and
international experience that he brings," said Hermes Chan, CEO, MedMira Inc. "Jelle's focus
will be on developing a strong financial and organisational
platform across our business as we push forward with our strategic
initiatives and product launches in the US and international
markets to drive positive growth in 2014.
Chan added, "Using his extensive range of
financial and business experience, Jelle will lead the development
and implementation of key financial and business information
systems aimed at streamlining processes and increasing efficiency
across the organization."
Prior to joining MedMira, Kuypers served in
senior finance and treasury roles in Canada, Switzerland and the Middle East with Rio Tinto Alcan, Sohar
Aluminum and Alcan Holdings Switzerland. He also worked for a
number of years as a management consultant with Mercer Management
Consulting and KPMG Treasury & Risk Management where he focused
on the areas of financial management, supply chain management,
controlling, and organizational redesign. He holds a master's
degree in Finance and Economics from the University of St. Gallen
(HSG), graduating as lic. oec. HSG. He also earned a CEMS Master's
in International Management (CEMS MIM) degree in International
Business and Strategies and International Controlling from the
Rotterdam School of Management, Erasmus
University.
About MedMira
MedMira is the leading developer and
manufacturer of flow-through rapid diagnostics and technologies.
MedMira is the only Canadian company to be awarded US Army
contracts for the development of rapid tests for HIV and Hepatitis
viruses. The Company's testing solutions provide hospitals,
labs, clinics and individuals with reliable, rapid diagnosis for
diseases such as HIV and hepatitis C in just three minutes. The
Company's tests are sold under the Reveal®, Multiplo™ and Miriad
brands in global markets. MedMira is located in Halifax, Nova Scotia, Canada.
www.medmira.com.
This news release contains forward-looking
statements, including statements relating to growth in the
Company's business, earnings and profitability, and trends in
demand for the Company's products, which involve risk and
uncertainties and reflect the Company's current expectation
regarding future events including statements regarding possible
future growth and new business opportunities. Actual events
could materially differ from those projected herein and depend on a
number of factors including, but not limited to, changing market
conditions, successful and timely completion of clinical studies,
uncertainties related to the regulatory approval process,
establishment of corporate alliances and other risks detailed from
time to time in the company quarterly filings.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE MEDMIRA INC.
